NEW YORK, Feb 15 – Basel, Switzerland-based bioinformatics company GeneData said Thursday that Novartis Pharma had licensed its Expressionist microarray data analysis system. 

The multi-year agreement is an extension of an existing collaboration between GeneData and Novartis Pharma’s Basel, Switzerland, research site that began three years ago.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.

A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.

The New York Times writes about the appearance of mosaicism in healthy people.

In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.